ISRCTN43895480已完成未知
Antifungal stewardship opportunities with rapid tests for fungal infection in critically ill patients
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 1,251
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- All
入选标准
- •Current participant inclusion criteria as of 11/04/2019:
- •1. Adults and children >4 weeks old
- •2. Admitted to a UK ICU (level 2 or 3)
- •3. Prescribed systemic antifungal therapy, for suspected or confirmed Candida infection, during the preceding 24 hours
- •Previous participant inclusion criteria:
- •1. Adults and children >4 weeks old
- •2. Admitted to a UK ICU (level 2 or 3)
- •3. Started systemic antifungal therapy, for presumed Candida infection, during the preceding 24 hours
排除标准
- •1. More than 24 hours systemic antifungal therapy in the preceding 7-days
- •2. Treatment with antifungal therapy for proven or suspected mould infection (eg.e.g. aspergillosis)
- •3. Neutropenia (absolute neutrophil count <0.5x109/L) during preceding 28 days
- •4. Acute leukaemia or within 12 months of bone-marrow transplantation
- •5. Hospitalised prisoners
- •6. Previously enrolled in this study
- •Added 26/10/2021:
- •7. Proven or suspected active infection with COVID-19
研究者
相似试验
招募中
不适用
Effective and safety using antifungal dropmycotic keratitisJPRN-UMIN000026811Toho university30
进行中（未招募）
1 期
A ß-d-glucan guided antifungal stewardship strategy for the management of patients with severe abdominal sepsis. A multicenter interventional explorative study with a pharmadynamic/pharmachokinetic substudy entitled: A Pilot substudy of Liposomal Amphotericin B Pharmacodynamics in Patients with Abdominal Sepsis” conducted only in the coordinating centerPatients with severe sepsis or septic shockMedDRA version: 23.1Level: PTClassification code 10066593Term: Post procedural sepsisSystem Organ Class: 10021881 - Infections and infestationsMedDRA version: 20.0Level: PTClassification code 10058040Term: Abdominal sepsisSystem Organ Class: 10021881 - Infections and infestationsEUCTR2016-002335-14-ITAOU DI BOLOGNA POLICLINICO S.ORSOLA-MALPIGHI40
已完成
不适用
Adjuvant Antifungal Therapy Using Tissue Tolerable Plasma on Oral Mucosa and Removable Dentures in Oral Candidiasis Patients: A Double-Blinded Split-Mouth Pilot Study.B37.0Candidal stomatitisDRKS00009368Charité Campus Benjamin Franklin8
尚未招募
不适用
Study of skin features, laboratory features and response to treatment to antifungal drugs in patients with superficial fungal infections.CTRI/2018/04/013045MAHARAJAHS INSTITUTE OF MEDICAL SCIENCES
进行中（未招募）
1 期
Empirical versus pre-emptive antifungal therapy of patients withhaematological malignanciesEmpirical versus pre-emptive (diagnosticdriven)antifungal therapy of patients treated for haematological malignancies or receiving an allogeneic stem cell transplant. A therapeutic open label phase IIIstrategy study of the EORTC Infectious Diseases and Leukemia Groups.Invasive fungal infection in patients with hematological malignancies.MedDRA version: 14.1Level: LLTClassification code 10017544Term: FungemiaSystem Organ Class: 10021881 - Infections and infestationsEUCTR2010-020814-27-NLEORTC556